Magdalena Łętowska
About
In The Last Decade
Magdalena Łętowska
56 papers receiving 407 citations
Peers
Comparison fields: 5 of 73
- Hepatology 193
- Epidemiology 172
- Hematology 137
- Management of Technology and Innovation 71
- Infectious Diseases 62
Countries citing papers authored by Magdalena Łętowska
This map shows the geographic impact of Magdalena Łętowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Łętowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Łętowska more than expected).
Fields of papers citing papers by Magdalena Łętowska
This network shows the impact of papers produced by Magdalena Łętowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Łętowska. The network helps show where Magdalena Łętowska may publish in the future.
Co-authorship network of co-authors of Magdalena Łętowska
This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Łętowska. A scholar is included among the top collaborators of Magdalena Łętowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Łętowska. Magdalena Łętowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | Diagnostyka molekularna SARS-CoV-2 | 0 |
| 7 | Analiza poważnych niepożądanych zdarzeń i poważnych niepożądanych reakcji poprzetoczeniowych w Polsce w latach 2011–2014. Część I. Poważne zdarzenia niepożądane i reakcje poprzetoczeniowe związane z obcogrupowym przetoczeniem składnika krwi | 0 |
| 8 | Charakterystyka testu cobas® MPX wraz z analizatorem cobas® 6800 oraz aparatem cobas p 680 (Roche) przeznaczonych do automatycznego badania dawców krwi w kierunku RNA wirusa zapalenia wątroby typu C (HCV), RNA ludzkiego wirusa nabytego niedoboru odporności (HIV) i DNA wirusa zapalenia wątroby typu B (HBV) | 0 |
| 9 | 4 | |
| 10 | Oznaczanie leukocytów w ubogoleukocytarnych składnikach krwi w systemie ADAM r-WBC | 0 |
| 11 | Ocena nieinwazyjnej metody oznaczania stężenia hemoglobiny we krwi przy użyciu aparatu Haemospect | 0 |
| 12 | 14 | |
| 13 | Wirus Zachodniego Nilu a bezpieczeństwo przetoczeń krwi i jej składników | 1 |
| 14 | Polskie zalecenia dotyczące leczenia antagonistami witaminy K | 0 |
| 15 | Choroby odkleszczowe w aspekcie bezpiecznego krwiodawstwa | 1 |
| 16 | Polish guidelines for the management of rare clotting factor deficiencies | 2 |
| 17 | Częstość zakażeń wirusem HIV w populacji krwiodawców w Polsce w latach 1988-2007 | 1 |
| 18 | 19 | |
| 19 | 11 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.